Keywords
opioid receptors
µ-receptor
pharmacodynamics
pharmacokinetics
How to Cite
Abstract
This scientific article systematically and comprehensively covers the chemical structure, pharmacokinetic and pharmacodynamic properties, and mechanisms of action of morphine — a member of the opioid analgesic group. Morphine modifies intracellular signaling via Gi/o proteins through µ-, κ-, and δ-opioid receptors, thereby inhibiting the transmission of nociceptive impulses in the central nervous system. The article also examines the drug's bioavailability, metabolic pathways, the clinical significance of M3G and M6G metabolites, adverse effects, mechanisms of dependence and tolerance, as well as its contemporary clinical applications.
References
1. Katzung B.G., Trevor A.J. Basic and Clinical Pharmacology. 14th ed. New York: McGraw-Hill Education, 2018. 1235 p.
2. Rang H.P., Dale M.M., Ritter J.M. et al. Rang and Dale's Pharmacology. 9th ed. Edinburgh: Elsevier, 2020. 808 p.
3. Trescot A.M., Datta S., Lee M., Hansen H. Opioid pharmacology. Pain Physician. 2008; 11(2 Suppl): S133–S153.
4. Pasternak G.W., Pan Y.X. Mu opioids and their receptors: evolution of a concept. Pharmacol Rev. 2013; 65(4):1257–1317.
5. Stein C. Opioid receptors. Annu Rev Med. 2016; 67:433–451. DOI: 10.1146/annurev-med-062613-093100.
This work is licensed under a Creative Commons Attribution 4.0 International License.
